- Enzymes
- Polysaccharides
- Nutrients
- Chemotherapeutic Agents
- Antibiotics
- Vaccines
The microbial-derived products market was valued at USD 192 billion in 2023 and is projected to grow at 8.7% CAGR over the forecast years to reach USD 344.3 billion by 2030. The microbial-derived products market is experiencing significant growth, driven by several factors such as the growing awareness and demand for sustainable solutions, stringent regulations promoting eco-friendly alternatives, and growing demand for organic food products. Consumers and industries alike are increasingly seeking eco-friendly alternatives. Microbial products offer a sustainable solution in areas like environmental management, healthcare, and agriculture. Microbial products can bioremediate polluted environments, create biofertilizers to improve soil health and develop natural pesticides for pest control. Governments around the world are enacting stricter regulations to promote environmentally friendly practices, this is leading to a rise in the demand for microbial products, which can comply with these regulations. The organic food market is booming, and there is a growing demand for products that are free from synthetic chemicals, microbial products can be used in organic food production, such as in biofertilizers and pest control. Despite the growth of the market shorter shelf life, complex storage requirements, and low adoption rates are some constraints that hinder market growth. However, opportunities such as large-scale investments in R&D and advancements in biotechnology and microbiology fields can boost the market growth. the microbial-derived products market is constantly evolving, and several key trends are shaping the future of the market such as the rise of personalized medicine, the use of microbes in bioplastics production, and the increasing use of microbial products in food production.
Recent Developments in the Microbial Derived Products Market
Oct 2021 - Shiru a startup based in CA producing protein via microbial fermentation receives $17 million to start its bio-fermentation platform, which produces label-friendly alternatives to anything from methylcellulose to gelatin
Microbial Derived Products Market Summary
Study Period
2024– 2030
Base Year
2023
CAGR
8.7%
Largest Market
North America
Fastest Growing Market
Asia pacific
Microbial Derived Products Market Dynamics
The microbial-derived products market growing due to the significant amount of investment being made in research and development (R&D) for microbial products. This is leading to the development of new and improved products with a wider range of applications. Advancements in these fields are allowing scientists to develop more efficient and effective ways to produce microbial products, this is making microbial products more cost-competitive with traditional products. The Rise of Personalized Medicine: Microbial products are being used to develop personalized medicine treatments, which are tailored to the individual patient's needs, and also used to develop new types of bioplastics, which are biodegradable and more sustainable than traditional plastics additional microbial products are being used to improve food safety, extend shelf life, and enhance the nutritional value of food.
North-America Got Significant Share
Microbial Derived Products Market Regional Analysis
Based on regions the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America reigns supreme in the microbial-derived product market, boasting the largest share thanks to robust research, clear regulations, and hefty healthcare spending. However, the Asia Pacific region is poised for the fastest growth due to its surging population, growing health consciousness, and government support for clinical research, making it a future contender in this microbial market landscape.
Latin America
Europe
Asia Pacific
Middle East
North America
Microbial Derived Products Market Segmentation
By Procedures
By Source
- Bacterial
- Viral
- Fungi
By End User
- Pharmaceutical Industries
- Biotechnological Industries
- Hospitals and Clinics
- Diagnostic Labs
- Research and Academics
Frequently Asked Questions
The microbial-derived products market was valued at USD 192 billion in 2023 and is projected to grow at 8.7% CAGR over the forecast years to reach USD 344.3 billion by 2030.
Market research report segments covered are type, source, end-user, and region
North America is the dominating region in the microbial-derived products market.
Asia-Pacific is the fastest-growing region in the microbial-derived products market
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
- The report provides a plethora of information about Market entry strategies, regulatory framework, and reimbursement scenarios.
| 1. Executive Summary |
| 2. Global Microbial Derived Products Market Introduction |
| 2.1.Global Microbial Derived Products Market - Taxonomy |
| 2.2.Global Microbial Derived Products Market - Definitions |
| 2.2.1.Procedures |
| 2.2.2.Source |
| 2.2.3.End Users |
| 2.2.4.Region |
| 3.Global Microbial Derived Products Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Microbial Derived Products Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Microbial Derived Products Market By Procedures , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Enzymes |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Polysaccharides |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Nutrients |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Chemotherapeutic Agents |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Antibiotics |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Vaccines |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Global Microbial Derived Products Market By Source, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Bacterial |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Viral |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Fungi |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Microbial Derived Products Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Pharmaceutical Industries |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Biotechnological Industries |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Hospitals and Clinics |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Diagnostic Labs |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Research and Academics |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global Microbial Derived Products Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Microbial Derived Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Procedures Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Enzymes |
| 9.1.2.Polysaccharides |
| 9.1.3.Nutrients |
| 9.1.4.Chemotherapeutic Agents |
| 9.1.5.Antibiotics |
| 9.1.6.Vaccines |
| 9.2. Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Bacterial |
| 9.2.2.Viral |
| 9.2.3.Fungi |
| 9.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Pharmaceutical Industries |
| 9.3.2.Biotechnological Industries |
| 9.3.3.Hospitals and Clinics |
| 9.3.4.Diagnostic Labs |
| 9.3.5.Research and Academics |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Microbial Derived Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Procedures Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Enzymes |
| 10.1.2.Polysaccharides |
| 10.1.3.Nutrients |
| 10.1.4.Chemotherapeutic Agents |
| 10.1.5.Antibiotics |
| 10.1.6.Vaccines |
| 10.2. Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Bacterial |
| 10.2.2.Viral |
| 10.2.3.Fungi |
| 10.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Pharmaceutical Industries |
| 10.3.2.Biotechnological Industries |
| 10.3.3.Hospitals and Clinics |
| 10.3.4.Diagnostic Labs |
| 10.3.5.Research and Academics |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Microbial Derived Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Procedures Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Enzymes |
| 11.1.2.Polysaccharides |
| 11.1.3.Nutrients |
| 11.1.4.Chemotherapeutic Agents |
| 11.1.5.Antibiotics |
| 11.1.6.Vaccines |
| 11.2. Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Bacterial |
| 11.2.2.Viral |
| 11.2.3.Fungi |
| 11.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Pharmaceutical Industries |
| 11.3.2.Biotechnological Industries |
| 11.3.3.Hospitals and Clinics |
| 11.3.4.Diagnostic Labs |
| 11.3.5.Research and Academics |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Microbial Derived Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Procedures Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Enzymes |
| 12.1.2.Polysaccharides |
| 12.1.3.Nutrients |
| 12.1.4.Chemotherapeutic Agents |
| 12.1.5.Antibiotics |
| 12.1.6.Vaccines |
| 12.2. Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Bacterial |
| 12.2.2.Viral |
| 12.2.3.Fungi |
| 12.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Pharmaceutical Industries |
| 12.3.2.Biotechnological Industries |
| 12.3.3.Hospitals and Clinics |
| 12.3.4.Diagnostic Labs |
| 12.3.5.Research and Academics |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Microbial Derived Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Procedures Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Enzymes |
| 13.1.2.Polysaccharides |
| 13.1.3.Nutrients |
| 13.1.4.Chemotherapeutic Agents |
| 13.1.5.Antibiotics |
| 13.1.6.Vaccines |
| 13.2. Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Bacterial |
| 13.2.2.Viral |
| 13.2.3.Fungi |
| 13.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Pharmaceutical Industries |
| 13.3.2.Biotechnological Industries |
| 13.3.3.Hospitals and Clinics |
| 13.3.4.Diagnostic Labs |
| 13.3.5.Research and Academics |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Kyowa Hakko Bio Co. |
| 14.2.2.GlaxoSmithKline plc |
| 14.2.3.NovaDigm Therapeutics |
| 14.2.4.Sanofi S.A |
| 14.2.5.Novartis AG |
| 14.2.6.Merck & Co. Inc. |
| 14.2.7.Valent BioSciences Corp. |
| 14.2.8.Amgen Inc. |
| 14.2.9.Pfizer Inc Ltd |
| 14.2.10.Biomérieux SA |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Kyowa Hakko Bio Co.
- GlaxoSmithKline plc
- NovaDigm Therapeutics
- Sanofi S.A
- Novartis AG
- Merck & Co. Inc.
- Valent BioSciences Corp.
- Amgen Inc.
- Pfizer Inc Ltd
- Biomérieux SA